IRIDEX Corporation appointed David Bruce to be the company's President and Chief Executive Officer, effective May 21, 2019. Mr. Bruce has been a member of IRIDEX's board of directors since April, 2018 and has held several CEO and leadership positions in both public and private medical device growth-stage companies. He served as CEO and Director of Arstasis.

The company thanked to outgoing CEO, William M. Moore.